Group One Trading’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Hold
0
2250
2023
Q1
Hold
0
2255
2022
Q4
Sell
-23,249
Closed -$212K 2320
2022
Q3
$212K Buy
+23,249
New +$212K ﹤0.01% 809